Schedule 13G ownership disclosure

Calithera Biosciences, Inc.

Security class unavailable · CUSIP: 13089P101

Event date: 2017-09-26

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,447,873
Percent of class
9.7200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-17-003800
Form type
SC 13G/A
Filer
ADAGE CAPITAL PARTNERS GP, L.L.C.
CIK
CIK 1165408
Filed
Sep 28, 2017
Reporting period
Sep 26, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub